Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review Manon J. PepelsJohanna H. M. J. VestjensVivianne C. G. Tjan-Heijnen Review 24 October 2010 Pages: 301 - 313
Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies Jia-Yi DongLi-Qiang Qin Review 27 November 2010 Pages: 315 - 323
Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation Michelle D. SluiterElizabeth J. van Rensburg Preclinical study 16 March 2010 Pages: 325 - 349
The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells Ming ShiDan LiuNing Guo Preclinical study 17 March 2010 Pages: 351 - 362
The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation Hongren YaoDonna M. VeineDonna L. Livant Preclinical study 19 March 2010 Pages: 363 - 375
Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of 131I by carbamazepine in breast cancer cells Michael J. WillhauckDennis J. O`KaneChristine Spitzweg Preclinical study 19 March 2010 Pages: 377 - 386
Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer E. A. ReijmM. P. H. M. JansenE. M. J. J. Berns Preclinical study 20 March 2010 Pages: 387 - 394
High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancer Özcan MetEva BalslevInge Marie Svane Preclinical study 25 March 2010 Pages: 395 - 406
Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors Yayun LiangCynthia Besch-WillifordSalman M. Hyder Preclinical study 27 March 2010 Pages: 407 - 420
Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis Sirkku PollariSanna-Maria KäkönenOlli Kallioniemi Preclinical study 30 March 2010 Pages: 421 - 430
Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials Joanne L. BlumJoseph KohlesStefan Glück Clinical trial 03 November 2010 Pages: 431 - 439
The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer G. J. van LondenS. PereraS. L. Greenspan Clinical trial 03 November 2010 Pages: 441 - 446
Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer Guy JerusalemAngelica FasoloLuca Gianni Clinical trial 25 November 2010 Pages: 447 - 455
Vascular endothelial growth factor receptor 2 and downstream p38 mitogen-activated protein kinase are possible candidate markers of intrinsic resistance to adjuvant endocrine treatment in steroid receptor positive breast cancer Barbro K. LinderholmHenrik HellborgJanne Lehtiö Clinical trial 26 November 2010 Pages: 457 - 465
Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis Weiguang YuanLidan XuDianjun Li Epidemiology 06 June 2010 Pages: 467 - 472
Lack of association between ATM C.1066-6T > G mutation and breast cancer risk: a meta-analysis of 8,831 cases and 4,957 controls Hong DingChen MaoQing Chen Epidemiology 11 June 2010 Pages: 473 - 477
A functional −77T>C polymorphism in XRCC1 is associated with risk of breast cancer Li LiuPeng YuanDongxin Lin Epidemiology 13 June 2010 Pages: 479 - 487
VEGF 936C>T polymorphism and breast cancer risk: evidence from 5,729 cases and 5,868 controls Dongying GuMeilin Wang Epidemiology 19 June 2010 Pages: 489 - 493
Possible risk modifications in the association between MnSOD Ala-9Val polymorphism and breast cancer risk: subgroup analysis and evidence-based sample size calculation for a future trial Yun ChenJianping Pei Epidemiology 22 June 2010 Pages: 495 - 504
Potent CYP2D6 Inhibiting drugs do not increase relapse rate in early breast cancer patients treated with adjuvant tamoxifen Nava Siegelmann-DanieliDaniel KurnikRonen Loebstein Epidemiology 01 July 2010 Pages: 505 - 510
Cadmium concentration in biological media of breast cancer patients Loreta StrumylaiteAlgirdas BoguseviciusLina Poskiene Epidemiology 06 July 2010 Pages: 511 - 517
Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the Women’s Healthy Eating and Living Study Cynthia A. ThomsonCheryl L. RockJohn P. Pierce Epidemiology 06 July 2010 Pages: 519 - 527
RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis Guo-Wu ZhouJia HuQiang Li Epidemiology 11 July 2010 Pages: 529 - 535
Association between two polymorphisms of ABCB1 and breast cancer risk in the current studies: a meta-analysis Pei-Hua LuMu-Xin WeiMin-Bin Chen Epidemiology 13 July 2010 Pages: 537 - 543
Relationship between diabetes and risk of second primary contralateral breast cancer Christopher I. LiJanet R. DalingKathleen E. Malone Epidemiology 13 July 2010 Pages: 545 - 551
HER2 status in a population-derived breast cancer cohort: discordances during tumor progression Ulla WilkingEva KarlssonJonas Bergh Epidemiology 14 July 2010 Pages: 553 - 561
Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk Christina JustenhovenElke SchaeffelerHiltrud Brauch Epidemiology 16 July 2010 Pages: 563 - 569
The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis Lin-Bo GaoPeng BaiLin Zhang Epidemiology 17 July 2010 Pages: 571 - 574
Risk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073 C allele and FGFR2 rs1219648 G allele in North China Xiao-Hui ChenXiao-Qing LiYu-Mei Feng Epidemiology 17 July 2010 Pages: 575 - 582
Individual responses to chemotherapy-induced oxidative stress Dora Il’yasovaKelly KennedyMark W. Dewhirst Brief Report 10 September 2010 Pages: 583 - 589
A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas Talia DonenbergJohn LunnJudith Hurley Brief Report 14 September 2010 Pages: 591 - 596
Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility was not credible: appraisal of a recent meta-analysis Pei-Hua LuXiu-Feng Huang Letter to the Editor 30 September 2010 Pages: 597 - 598
Need for clarification of results in the recent meta-analysis about SULT1A1 codon 213 polymorphism and breast cancer risk Pei-Hua LuMu-Xin WeiMin-Bin Chen Letter to the Editor 15 October 2010 Pages: 599 - 600
No significant association results obtained from significant association evidence: the ongoing uncertainty of TP53 codon 72 polymorphism and breast cancer risk Pei-Hua LuGuo-Qing TaoMu-Xin Wei Letter to the Editor 21 October 2010 Pages: 601 - 603
